Document Type

Article

Publication Title

Virginia Law Review

Abstract

The article discusses the U.S. Supreme Court's decision on the lawsuit filed by MedImmune Inc. against Genentech Inc. It reveals that the court's ruling reverses its decision made on a patent suit involving Lear which allowed a licensee in good standing to challenge the validity of a licensed patent. The author also examines the impact of shifting the risk of invalidation to patents, such as reducing their incentives to invest on innovations.

First Page

677

DOI

https://doi.org/10.2307/1072909

Volume

72

Publication Date

1986

Download

Share

COinS